Futura Medical plc
Futura Medical plc research, develops, and commercializes pharmaceutical and healthcare products for sexual health. The company's lead product includes Eroxon, a topical gel for the treatment of erectile dysfunction. It also develops WSD4000 for the treatment of sexual dysfunction in women. The company operates in the United Kingdom, the European Union, the United States, and internationally. Fut… Read more
Futura Medical plc (FAMDF) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2025: -0.978x
Based on the latest financial reports, Futura Medical plc (FAMDF) has a cash flow conversion efficiency ratio of -0.978x as of June 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-2.98 Million) by net assets ($3.05 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Futura Medical plc - Cash Flow Conversion Efficiency Trend (2000–2024)
This chart illustrates how Futura Medical plc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Futura Medical plc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Futura Medical plc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Grand Green Energy Co., LTD.
TWO:6639
|
-0.026x |
|
Jade Marvel Group Bhd
KLSE:7043
|
-0.019x |
|
e-future.Co.Ltd
KQ:134060
|
0.012x |
|
Pescanova SA
MC:PVA
|
0.084x |
|
STAK Inc. Ordinary Shares
NASDAQ:STAK
|
N/A |
|
VERTEX RESOURCE
F:4X8
|
N/A |
|
Quantum Genomics Société Anonyme
PINK:QNNTF
|
3.110x |
|
Myseum, Inc.
NASDAQ:MYSE
|
-0.159x |
Annual Cash Flow Conversion Efficiency for Futura Medical plc (2000–2024)
The table below shows the annual cash flow conversion efficiency of Futura Medical plc from 2000 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $8.96 Million | $391.47K | 0.044x | -58.05% |
| 2023-12-31 | $5.48 Million | $570.25K | 0.104x | +108.51% |
| 2022-12-31 | $4.72 Million | $-5.78 Million | -1.224x | -207.24% |
| 2021-12-31 | $9.72 Million | $-3.87 Million | -0.398x | +92.52% |
| 2020-12-31 | $853.54K | $-4.54 Million | -5.323x | +95.71% |
| 2019-12-31 | $53.65K | $-6.66 Million | -124.063x | -23226.94% |
| 2018-12-31 | $8.85 Million | $-4.71 Million | -0.532x | -16.00% |
| 2017-12-31 | $9.11 Million | $-4.17 Million | -0.458x | -74.94% |
| 2016-12-31 | $12.58 Million | $-3.30 Million | -0.262x | +76.61% |
| 2015-12-31 | $4.79 Million | $-5.36 Million | -1.121x | -255.27% |
| 2014-12-31 | $9.72 Million | $-3.07 Million | -0.315x | +84.53% |
| 2013-12-31 | $987.77K | $-2.01 Million | -2.039x | -201.85% |
| 2012-12-31 | $2.87 Million | $-1.94 Million | -0.675x | -1.47% |
| 2011-12-31 | $2.76 Million | $-1.84 Million | -0.666x | +42.78% |
| 2010-12-31 | $900.00K | $-1.05 Million | -1.163x | -63.56% |
| 2009-12-31 | $1.85 Million | $-1.32 Million | -0.711x | +68.03% |
| 2008-12-31 | $886.00K | $-1.97 Million | -2.225x | -170.33% |
| 2007-12-31 | $2.77 Million | $-2.28 Million | -0.823x | -75.47% |
| 2006-12-31 | $3.95 Million | $-1.85 Million | -0.469x | +56.30% |
| 2005-12-31 | $1.98 Million | $-2.12 Million | -1.073x | -177.22% |
| 2004-12-31 | $3.75 Million | $-1.45 Million | -0.387x | +31.27% |
| 2003-12-31 | $2.41 Million | $-1.36 Million | -0.563x | +19.43% |
| 2002-12-31 | $1.52 Million | $-1.06 Million | -0.699x | -8.85% |
| 2001-12-31 | $2.00 Million | $-1.28 Million | -0.642x | -159.76% |
| 2000-12-31 | $-294.00K | $-316.00K | 1.075x | -- |